Fenbendazole

Cross-source consensus on Fenbendazole from 1 sources and 6 claims.

1 sources · 6 claims

How it works

Fenbendazole is an inexpensive antiparasitic drug costing $5–$12 with an expired patent, originally developed to kill parasitic worms. — Cancer Is a Parasite
Fenbendazole works by binding directly to tubulin proteins, breaking down the cytoskeletal scaffold cancer cells require for division. — Cancer Is a Parasite
No major cancer center is conducting clinical trials on fenbendazole because its expired patent makes pharmaceutical investment financially unrecoverable. — Cancer Is a Parasite
Most fenbendazole cancer research originates from universities in South Korea and India with no industry funding and no conflicts of interest. — Cancer Is a Parasite
A 2025 study showed fenbendazole targets cancer stem cells — which survive chemotherapy and regrow tumors — achieving 100% survival in treated mice versus zero in untreated controls. — Cancer Is a Parasite
Fenbendazole brought three stage-4 cancer patients into complete remission in 2025. — Cancer Is a Parasite